Literature DB >> 12829456

Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease.

William D-C Man1, Mohamed G G Soliman, Johanne Gearing, Sheena G Radford, Gerrard F Rafferty, Barry J Gray, Michael I Polkey, John Moxham.   

Abstract

Patients with chronic obstructive pulmonary disease (COPD) may stop cycling due to leg effort rather than breathlessness. However, cycling is not relevant to many patients, although walking may be more familiar. A total of 84 patients with COPD were asked to name the predominant symptom limiting incremental shuttle walking, endurance shuttle walking, incremental cycle ergometry, and endurance cycle ergometry, performed to exhaustion on four separate days. Furthermore, quadriceps fatigability was evaluated in 12 patients by measuring unpotentiated and potentiated twitch quadriceps tensions before and 30 minutes after incremental walking and cycling. Breathlessness alone was a more commonly cited limiting symptom after incremental walking compared with incremental cycling (81 vs. 34%; p < 0.001) and after endurance walking compared with endurance cycling (75 vs. 29%; p < 0.001). In addition, there was no significant change in mean pre- and postwalking twitch quadriceps tensions. However, cycling produced a significant reduction (unpotentiated 7.42 +/- 2.22 vs. 6.48 +/- 2.09 kg [p < 0.001]; potentiated 10.19 +/- 3.99 vs. 8.45 +/- 3.18 kg [p < 0.001]). Pre- to postexercise changes were significantly greater during cycling compared with walking (unpotentiated p = 0.01; potentiated p = 0.003). Leg effort is an infrequent symptom after walking in COPD, and low frequency fatigue of the quadriceps is an infrequent feature of incremental walking.

Entities:  

Mesh:

Year:  2003        PMID: 12829456     DOI: 10.1164/rccm.200302-162OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  30 in total

1.  Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease.

Authors:  Véronique Pepin; Julie Brodeur; Yves Lacasse; Julie Milot; Pierre Leblanc; François Whittom; François Maltais
Journal:  Thorax       Date:  2006-11-10       Impact factor: 9.139

2.  Assessing the exercise response to a bronchodilator in COPD: time to get off your bike?

Authors:  M D L Morgan; S J Singh
Journal:  Thorax       Date:  2007-04       Impact factor: 9.139

3.  Pathophysiological adaptations to walking and cycling in primary pulmonary hypertension.

Authors:  G Valli; C D Vizza; P Onorati; R Badagliacca; R Ciuffa; R Poscia; F Brandimarte; F Fedele; P Serra; P Palange
Journal:  Eur J Appl Physiol       Date:  2007-11-03       Impact factor: 3.078

4.  Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial.

Authors:  Michael I Polkey; Jens Praestgaard; Amy Berwick; Frits M E Franssen; Dave Singh; Michael C Steiner; Richard Casaburi; Hanns-Christian Tillmann; Estelle Lach-Trifilieff; Ronenn Roubenoff; Daniel S Rooks
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 21.405

Review 5.  Aspects of skeletal muscles in chronic respiratory disease.

Authors:  William D-C Man
Journal:  Chron Respir Dis       Date:  2016-08       Impact factor: 2.444

Review 6.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

7.  Comparison of the six-minute walk test with a cycle-based cardiopulmonary exercise test in people following curative intent treatment for non-small cell lung cancer.

Authors:  Vinicius Cavalheri; Sue Jenkins; Nola Cecins; Kevin Gain; Kylie Hill
Journal:  Chron Respir Dis       Date:  2016-02-11       Impact factor: 2.444

8.  Benefits of Physical Training in Sarcoidosis.

Authors:  Bert Strookappe; Jeff Swigris; Jolanda De Vries; Marjon Elfferich; Ton Knevel; Marjolein Drent
Journal:  Lung       Date:  2015-08-19       Impact factor: 2.584

9.  Development and implementation of treadmill exercise testing protocols in COPD.

Authors:  Christopher B Cooper; Marlon Abrazado; Daniel Legg; Steven Kesten
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-10-12

10.  Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD.

Authors:  W D C Man; N Mustfa; D Nikoletou; S Kaul; N Hart; G F Rafferty; N Donaldson; M I Polkey; J Moxham
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.